Dallas, TX, United States of America

Yang-Xin Fu

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 4.2

ph-index = 1


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: Innovations and Contributions of Inventor Yang-Xin Fu

Introduction

Yang-Xin Fu is a notable inventor based in Dallas, TX (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic methods and compositions. With a total of 3 patents, his work focuses on innovative solutions for treating various diseases and disorders.

Latest Patents

Among his latest patents, Yang-Xin Fu has developed novel fusion proteins of Interleukin 15 and prodrugs. These compositions and methods are useful in treating conditions such as hyperplasia, solid tumors, and hematopoietic malignancies. Additionally, he has disclosed methods for sequential treatment of cancers using 6-thio-2'-deoxyguanosine (6-thio-dG), checkpoint inhibitors, and radiation therapy. This approach has shown promise in leading to tumor regression through innate and adaptive immune-dependent mechanisms in syngeneic and humanized mouse cancer models.

Career Highlights

Yang-Xin Fu has worked with prominent organizations, including the University of Texas System and Immune Targeting, Inc. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Throughout his career, Yang-Xin Fu has collaborated with esteemed colleagues, including Jerry W. Shay and Ilgen Mender. These partnerships have fostered innovation and enhanced the impact of his work in the field.

Conclusion

Yang-Xin Fu's contributions to biotechnology and his innovative patents highlight his role as a leading inventor in the industry. His work continues to pave the way for advancements in therapeutic methods and compositions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…